drugset / Trial / NCT01396161
A Study of PF-05175157 in Healthy Volunteers and Type 2 Diabetic Patients
RandomizedDouble-blindBasic science
Summary
The primary purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of PF-05175157 in healthy volunteers and patients with type 2 diabetes mellitus.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-02
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-05175157 | Small molecule | 30 mg | Oral |
| Subject | PF-05175157 | Small molecule | 100 mg | Oral |
| Subject | PF-05175157 | Small molecule | 200 mg | Oral |